Donald J. Trump
http://www.trumponline.com/Donald Trump is a real estate developer, American business executive, and entrepreneur. He is the CEO of Trump Organization, a real estate development company based in New York.
Trump graduated from the Wharton School of Business at the University of Pennsylvania in 1968 with a BS in economics and a concentration in finance. He then joined his father's company, the Trump Organization, where he developed and revitalized properties in Manhattan.
Trump found additional success as a TV star on the hit show The Apprentice, where he coined the term 'You're Fired!'.
In 2016, Trump ran for President of the U.S. as a Republican. After topping a large field of 16 other Republicans he was selected as the nominees. He then faced Democrat Hillary Clinton and beat her in a contentious race to become President of the U.S. Trump's platform of 'Make America Great Again' and 'Drain the Swamp' resonated with white, working class citizens.
-
Novan President and CEO, Paula Brown Stafford Named Chairman of the Board
-
EU governments ban malaria drug for COVID-19, trial paused as safety fears grow
-
Novartis sales, profits rise in first quarter on COVID-19 buying rush
-
Coronavirus drug hopefuls are cheap to make but may be in short supply
-
Dozens of Swiss companies keen on export channel to Iran
-
European shares dip, Glencore slides to three-year low
-
Wall Street ends down amid more trade woes, high volatility
-
European shares end trade-driven losing run but worries linger
-
Merger cheer, Sanofi lift European shares; Fed in focus
-
Take Five: G7 - deep in the Woods?
-
Exclusive: Big Pharma returning to U.S. price hikes in January after pause
-
Takeda CEO confident of investor backing for $62 billion Shire deal
-
Novartis links bonuses to ethics in bid to rebuild reputation
-
Novartis recruits new compliance head from Siemens after ethics stumbles
-
Stock investors rediscover defensives before trade war deadlines
-
Tech lifts European shares as currency weakens; autos climb
-
Novartis hints at 2018 outlook hike despite drug price freeze
-
Novartis disputes U.S. senators' report on Cohen contract
-
Novartis hands investors Alcon spin-off, $5 billion share buyback
-
Michael Cohen seeks to keep Stormy Daniels' lawyer out of N.Y. case
-
FDA names drugmakers potentially acting to delay cheap generics
-
Novartis top lawyer exits over Trump attorney deal 'mistake'
-
Trump assails high drug prices, avoids direct hit on industry
-
AT&T CEO: We made 'big mistake' hiring Cohen, chief lobbyist out
-
Novartis calls $1.2 million deal with Trump lawyer's firm a 'mistake'
-
Wall Street rises but pares gains late after report of FBI raid
-
Exclusive: U.S. health regulator Verma eyes new methods for drug pricing
-
Novartis CEO sees no need for big takeover
-
How drugmakers face global push-back on high prices
-
After Trump rally, equity investors move into healthcare, retailers
-
'It's like kumbaya': Trump's genial private meetings with CEOs jar with public attacks
-
New GlaxoSmithKline CEO prepares for R&D choices, potential deals
-
Swiss vote on multinational tax perks in February referendum
-
Davos CEOs 'go local' on supply chain in Trump era
-
Tech, bank shares slip after recent gains; health outperforms

